Pancreatic ductal adenocarcinoma contains an effector and regulatory immune cell infiltrate that is altered by multimodal neoadjuvant treatment.
<h4>Objective</h4>The immune response to pancreatic ductal adenocarcinoma (PDA) may play a role in defining its uniquely aggressive biology; therefore, we sought to clearly define the adaptive immune infiltrate in PDA.<h4>Design</h4>We used immunohistochemistry and flow cytometry to characterize the...
Wedi'i Gadw mewn:
| Prif Awduron: | , , , , , , , , , , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Public Library of Science (PLoS)
2014-01-01
|
| Cyfres: | PLoS ONE |
| Mynediad Ar-lein: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0096565&type=printable |
| Tagiau: |
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|
